CRISPR/Cas9 technology generated a 53 bp deletion in exon 3 (which is common to all predicted transcripts). Immunofluorescence assays confirmed absence of protein expression in the testis and epididymis. (J:307639)
查看原文 参与反馈
CRISPR/Cas9 technology generated a 53 bp deletion in exon 3 (which is common to all predicted transcripts). Immunofluorescence assays confirmed absence of protein expression in the testis and epididymis. (J:307639)